Ebola cases in West Africa continue to rise
3 July 2014 | By Public Health England
PHE and other stakeholders providing technical support to the affected countries...
List view / Grid view
News
Mass spectrometry-based metabolics – an exclusive online-only article from Tun-Li Shen at Brown University
3 July 2014 | By Tun-Li Shen, Brown University
Tun-Li Shen provides a brief overview of the gas chromatography mass spectrometry (GC-MS) and liquid chromatography mass spectrometry (LC-MS) instrumentation platforms used in untargeted metabolomics studies...
GSK statement on UK Government-initiated review of antibiotic resistance
3 July 2014 | By GlaxoSmithKline
“We welcome today’s announcement of a review to explore the economic issues surrounding antimicrobial resistance..."
Midatech appoints Nick Robbins-Cherry as Finance Director
2 July 2014 | By Midatech
Midatech Ltd. is pleased to announce that Nick Robbins-Cherry has been appointed as Finance Director, further strengthening the Company’s senior management team...
Pfizer Inc. receives kosher certification for Elelyso™ (taliglucerase alfa) for injection, for the treatment of Type 1 Gaucher disease
2 July 2014 | By Pfizer
Pfizer Inc. announced that the Orthodox Union has granted kosher certification to ELELYSO™ (taliglucerase alfa) for injection, an enzyme replacement therapy for the long-term treatment of adults with a confirmed diagnosis of Type 1 Gaucher disease...
Boehringer Ingelheim submits applications in Europe for tiotropium + olodaterol Respimat® fixed-dose combination in COPD
2 July 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced submission of Marketing Authorisation Applications in 31 European countries for the once-daily fixed-dose combination of tiotropium + olodaterol in the Respimat® Soft Mist™ Inhaler...
Roche announces definitive agreement to acquire Seragon Pharmaceuticals
2 July 2014 | By Roche
Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast cancer...
Actavis plc appoints new members and announces changes to Board of Directors following close of Forest Laboratories, Inc. acquisition
2 July 2014 | By Actavis
Actavis plc announced the appointment of three new members to the Company's Board of Directors, including Actavis' newly appointed CEO and President, Brenton L. Saunders...
12th Takamine Memorial Daiichi Sankyo Prize winner announced
2 July 2014 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced that its affiliated foundation, the Daiichi Sankyo Foundation of Life Science has awarded its 12th Takamine Memorial Daiichi Sankyo Prize...
Torch V10.3 delivers intuitive visualization and analysis tools for multiple parameter optimization
1 July 2014 | By kdm communications
Cresset, innovative provider of computational chemistry software and services, announces the release of Torch V10.3...
GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma
1 July 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced the submission of a supplemental New Drug Application to the US Food and Drug Administration for a fixed dose combination of the inhaled corticosteroid, fluticasone furoate and the long-acting beta2 agonist, vilanterol...
European Medicines Agency releases revised guidance on advanced-therapy classification for public consultation
1 July 2014 | By The European Medicines Agency
The European Medicines Agency’s Committee for Advanced Therapies has revised a reflection paper on the classification of advanced-therapy medicinal products to reflect the current thinking of the committee on how ATMPs should be classified...
Johnson & Johnson completes divestiture of Ortho-Clinical Diagnostics to The Carlyle Group
1 July 2014 | By Johnson & Johnson
Johnson & Johnson announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion...
Merck announces data from investigational Phase 3 study on EMEND® (aprepitant) for the prevention of chemotherapy-induced nausea and vomiting (CINV) in children undergoing emetogenic chemotherapy
1 July 2014 | By Merck
Merck planning regulatory submissions in the U.S. for EMEND® in pediatric setting including new suspension formulation in second half of 2014...
Roche launches fully automated urine testing analyzer for enhanced result reliability and staff safety
30 June 2014 | By Roche
Roche announced the launch of cobas® 6500, a fully automated urine testing system that consists of two modular analyzers combining urine strip testing and digital urinary microscopy...
